Literature DB >> 28213624

Oligometastatic colorectal cancer: is single-site bony colorectal metastasis a treatable condition?

Noel Cassar1, Adrian Ben Cresswell2, Brendan Moran2.   

Abstract

INTRODUCTION: A potentially resectable bony metastasis in the context of oligometastatic colorectal cancer is uncommon. Bony metastases are usually considered a late event with poor prognosis and generally associated with liver and/or lung metastases. INDEX CASE: A previously healthy 33-year-old gentleman, with no family history of colorectal cancer, presented with rectal bleeding and at colonoscopy had a biopsy-proven adenocarcinoma of the rectum, 7 cm from the anal verge. Imaging also showed an isolated bone metastasis in the left ischial tuberosity. Following recovery from an anterior resection and a segment 5 metastasectomy, he underwent resection of the bony metastasis with a left type 3 internal hemipelvectomy. Three years from the bony resection, there is no evidence of recurrence on imaging. DISCUSSION: Osseous metastases are usually treated with palliative intent with bisphosphonates or external radiation, with surgical fixation of pathological fractures in some cases. Median survival after diagnosis of bone metastases is less than 10 months. Surgery is perhaps the only way of potentially achieving cure in patients with single-site bony metastases from colorectal cancer. Reports of such surgery in the literature are however very scant.
CONCLUSION: Our case is unusual and ongoing follow up is required. However, current disease-free status at conventional and functional imaging is encouraging. A multidisciplinary and indeed multicentre approach may be needed, and oligometastatic disease, even to a bone, may be amenable to curative surgical intervention in highly selected cases.

Entities:  

Keywords:  Colorectal carcinoma; Disease-free survival; Metastasectomy; Multidisciplinary communication

Mesh:

Year:  2017        PMID: 28213624     DOI: 10.1007/s00384-017-2780-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  7 in total

1.  Sternal metastasis as initial presentation of a unknown rectal cancer.

Authors:  G Scuderi; A Macrì; G Sfuncia; F Fedele; F Crescenti; A Versaci; G Altavilla; C Famulari
Journal:  Int J Colorectal Dis       Date:  2004-01-28       Impact factor: 2.571

2.  Metastatic colon cancer to the hand.

Authors:  T Clark Gamblin; Ricardo S Santos; Mark Baratz; Rodney J Landreneau
Journal:  Am Surg       Date:  2006-01       Impact factor: 0.688

3.  Bone metastasis.

Authors:  Ranen Kanti Aich; Ghosh Suman; Gupta Phalguni; Bhattacharya Jibak; Das Diptimoy
Journal:  J Cancer Res Ther       Date:  2014 Apr-Jun       Impact factor: 1.805

4.  Long-term disease-free survival after surgical resection for multiple bone metastases from rectal cancer.

Authors:  Seok Jin Choi; Jong Hun Kim; Min Ro Lee; Chang Ho Lee; Ja Hong Kuh; Jung Ryul Kim
Journal:  World J Clin Oncol       Date:  2011-08-10

5.  Isolated metastasis of colon cancer to the scapula: is surgical resection warranted?

Authors:  Jill K Onesti; Christopher R Mascarenhas; Mathew H Chung; Alan T Davis
Journal:  World J Surg Oncol       Date:  2011-10-26       Impact factor: 2.754

6.  Unusual bony colorectal metastases in post-hepatometastasectomy patients.

Authors:  Aali J Sheen; David Drake; Stephen Langton; David J Sherlock
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

Review 7.  The surgical treatment of pelvic bone metastases.

Authors:  Daniel A Müller; Rodolfo Capanna
Journal:  Adv Orthop       Date:  2015-02-24
  7 in total
  2 in total

1.  Outcome of surgical treatment for bone metastases caused by colorectal cancer.

Authors:  Martina Byttner; Rikard Wedin; Henrik Bauer; Panagiotis Tsagozis
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  The risk factors for bone metastases in patients with colorectal cancer.

Authors:  An-An Li; Zhi-Yuan Cao; Jia-Ming Liu; Shan-Hu Huang; Zhi-Li Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.